Billionaire Profile
P
Global Rank
#1364

Image: Unknown Author | CC BY-SA 4.0 | via Wikimedia Commons

P.V. Ramprasad Reddy

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$3.039B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+0.44% (24h)
Age
67
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

P.V. Ramprasad Reddy is an Indian business magnate and the co-founder of Aurobindo Pharma, a leading global pharmaceutical company. His estimated net worth is $3.9 Billion as of October 9, 2024. He is recognized as a key figure in the pharmaceutical industry, known for his strategic planning and leadership. Reddy co-founded Aurobindo Pharma in 1986, transforming it into a major player in the generic drug market. His career includes key roles such as Executive Chairman of Aurobindo Pharma USA Inc. He is recognized for his dedication to affordable healthcare and contributions to the pharmaceutical sector, earning him the Padma Shri award in 2010, the Ernst & Young Entrepreneur of the Year award in 2011, and the FICCI Businessman of the Year award in 2012.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

P.V. Ramprasad Reddy was born in Gudur, Andhra Pradesh, India, on August 15, 1957. He grew up in a farming family and learned the value of hard work and diligence early on. He completed his Bachelor of Commerce (B.Com) and Master of Commerce (M.Com) degrees at Sri Venkateswara University.

Rise to Success

Reddy's career began in the pharmaceutical industry in 1986 when he co-founded Aurobindo Pharma with his brother-in-law. Under his leadership, Aurobindo Pharma grew from a small company to one of the largest pharmaceutical companies in India and a major global player. The company's revenue comes primarily from exports to over 150 countries. In 2016, he was ranked #27 in India and #688 globally on the Forbes list of billionaires.

Key Business Strategies

Aurobindo Pharma has focused on developing and manufacturing high-quality generic versions of essential drugs, making treatment accessible to millions. The company's strategy includes a well-integrated and nimble manufacturing approach, with a low-risk strategy and a focus on formulations. Reddy's strategic intent has been to grow the company through consistent price discipline and acquisitions, including the acquisition of Actavis. The company's revenue reached approximately $2.6 Billion from 2017 to 2018.

Philanthropy

Reddy is known for his philanthropic activities. He established the Aurobindo Foundation in 1996, which focuses on providing healthcare, education, and social welfare services to the underprivileged.

Career Milestones

1986

Co-founded Aurobindo Pharma

Co-founded Aurobindo Pharma with his brother-in-law.

2006

Invited to Speak at the UN

Invited by then-UN Secretary-General Kofi Annan to speak at the United Nations.

2008

Recognized as Top Influential Person

Recognized as one of the top 35 most influential people in the pharmaceutical industry by World Pharmaceutical Frontiers.

2010

Padma Shri Award

Awarded the Padma Shri, the fourth-highest civilian award in India.

2011

Ernst & Young Entrepreneur of the Year

Awarded the Ernst & Young Entrepreneur of the Year award.

2012

FICCI Businessman of the Year

Awarded the FICCI Businessman of the Year award.

2017

Executive Chairman of Aurobindo Pharma USA Inc.

Appointed as Executive Chairman of Aurobindo Pharma USA Inc.

Philanthropy & Social Impact

Healthcare, Education, Social Welfare

Aurobindo Foundation

Millions

Provides healthcare, education, and social welfare services.

Business Philosophy & Leadership

Notable Quotes

"If you can't afford the medicine, what's the use of innovation?"

Leadership Principles

Human Lives Over Profit

Prioritizing public health and well-being above corporate profit margins is vital.

Innovation for All

Innovation must be coupled with a deep sense of social responsibility to ensure the accessibility of treatments.

Defiance for a Cause

Sometimes, challenging the status quo is necessary to create positive change.